Differently, C3 was featured as low immune and stromal scores, high mutation burden of FGFR3, luminal subtypes of BLCA, activation of fatty acid metabolism pathway, early stage of tumor, as well as a highest survival rate. The gene discussed is FGFR3; the disease is neoplasm.